BRAT1 encephalopathy: a recessive cause of epilepsy of infancy with migrating focal seizures.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
09 2020
Historique:
accepted: 04 11 2019
pubmed: 24 12 2019
medline: 15 12 2020
entrez: 24 12 2019
Statut: ppublish

Résumé

Epilepsy of infancy with migrating focal seizures (EIMFS), one of the most severe developmental and epileptic encephalopathy syndromes, is characterized by seizures that migrate from one hemisphere to the other. EIMFS is genetically heterogeneous with 33 genes. We report five patients with EIMFS caused by recessive BRAT1 variants, identified via next generation sequencing. Recessive pathogenic variants in BRAT1 cause the rigidity and multifocal seizure syndrome, lethal neonatal with hypertonia, microcephaly, and intractable multifocal seizures. The epileptology of BRAT1 encephalopathy has not been well described. All five patients were profoundly impaired with seizure onset in the first week of life and focal seizure migration between hemispheres. We show that BRAT1 is an important recessive cause of EIMFS with onset in the first week of life, profound impairment, and early death. Early recognition of this genetic aetiology will inform management and reproductive counselling.

Identifiants

pubmed: 31868227
doi: 10.1111/dmcn.14428
doi:

Substances chimiques

BRAT1 protein, human 0
Nuclear Proteins 0

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1096-1099

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Mac Keith Press.

Références

Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia 1995; 36: 1017-24.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 512-21.
Barba C, Darra F, Cusmai R, et al. Congenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy. Dev Med Child Neurol 2016; 58: 1085-91.
Milh M, Falace A, Villeneuve N, et al. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat 2013; 34: 869-72.
Poduri A, Heinzen EL, Chitsazzadeh V, et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol 2013; 74: 873-82.
Stodberg T, McTague A, Ruiz AJ, et al. Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures. Nat Commun 2015; 6: 8038.
Burgess R, Wang S, McTague A, et al. Genetic landscape of epilepsy of infancy with migrating focal seizures. Ann Neurol 2019; 86: 821-31.
McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol 2016; 15: 304-16.
Puffenberger EG, Jinks RN, Sougnez C, et al. Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS ONE 2012; 7: e28936.
Smith NJ, Lipsett J, Dibbens LM, Heron SE. BRAT1-associated neurodegeneration: intra-familial phenotypic differences in siblings. Am J Med Genet A 2016; 170: 3033-8.
Srivastava S, Olson HE, Cohen JS, et al. BRAT1 mutations present with a spectrum of clinical severity. Am J Med Genet A 2016; 170: 2265-73.
Van Ommeren RH, Gao AF, Blaser SI, Chitayat DA, Hazrati LN. BRAT1 mutation: the first reported case of Chinese origin and review of the literature. J Neuropathol Exp Neurol 2018; 77: 1071-8.
Ko A, Youn SE, Kim SH, et al. Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy. Epilepsy Res 2018; 141: 48-55.
Horn D, Weschke B, Knierim E, et al. BRAT1 mutations are associated with infantile epileptic encephalopathy, mitochondrial dysfunction, and survival into childhood. Am J Med Genet A 2016; 170: 2274-81.
Saitsu H, Yamashita S, Tanaka Y, et al. Compound heterozygous BRAT1 mutations cause familial Ohtahara syndrome with hypertonia and microcephaly. J Hum Genet 2014; 59: 687-90.

Auteurs

Ingrid E Scheffer (IE)

Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia.
Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia.
Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, Royal Children's Hospital, Parkville, Victoria, Australia.

Katja E Boysen (KE)

Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia.

Amy L Schneider (AL)

Epilepsy Research Centre, Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia.

Candace T Myers (CT)

Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.

Michele G Mehaffey (MG)

Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.

Anne M Rochtus (AM)

Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Harvard Medical School, Boston, MA, USA.

Yuet-Ping Yuen (YP)

Hong Kong Children's Hospital, Hong Kong.

Gabriel M Ronen (GM)

Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Wai Km Chak (WK)

Tuen Mun Hospital, New Territories, West Cluster, Hong Kong.

Deepak Gill (D)

T. Y. Nelson Department of Neurology and Neurosurgery, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Annapurna Poduri (A)

Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Department of Neurology, Harvard Medical School, Boston, MA, USA.

Heather C Mefford (HC)

Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH